47 completed. 47 Phase 2, 9 Phase 1, 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 47 | Completed 47 |
| Phase 1 | 9 | Completed 9 |
| Phase 3 | 9 | Completed 9 |
Follow control group: new trials by email Literature Review of control group trials Research Report on control group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validity of Ozonated Olive Oil Gel Versus Injectable Bone Graft Immediate implant placement, β-tricalcium phosphate Injectable Bone Graft, Ozonated olive oil gel - Dental, Implant Osseointegration | Phase 2 | Completed | Suez Canal University | 16 | 2023-12-10 | 2026-01-26 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis open flap debridement and Hyaluronic Acid-Based Gel application, open flap debridement - Periodontitis (Stage 3) | Phase 1 / Phase 2 | Completed | Ordu University | 18 | 2023-04-04 | 2025-02-24 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) RSVt Vaccine, Control Group - Respiratory Syncytial Virus Infection | Phase 1 / Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 80 | 2023-02-06 | 2026-01-26 |
| Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery Bupivacain, Bupivacaine and Magnesium sulfate, Bupivacaine and Dexmedetomidine ile Blokaj - Breast Cancer, Post Operative Pain | Phase 2 | Completed | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 75 | 2022-08-01 | 2025-07-23 |
| Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain Propranolol Hydrochloride, Placebo, Reactivation procedure - Chronic Low-back Pain, Fibromyalgia | Phase 2 | Completed | Université de Sherbrooke | 48 | 2022-02-07 | 2025-09-26 |
| Analgesic Effect of Bilateral Erector Spinae Plane Block With Ropivacaine After Sternotomy for Cardiac Surgery Ropivacaine 0,2% Injectable Solution, Control group - Cadiac Surgery, Median Sternotomy | Phase 2 | Completed | University Hospital, Clermont-Ferrand | 84 | 2021-10-20 | 2023-07-06 |
| Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases Control Group, Test Group - Pelvic Inflammatory Disease | Phase 2 | Completed | University of Karachi | 198 | 2021-09-21 | 2023-04-04 |
| Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI Rutan 25 mg, Control group - COVID-19 Respiratory Infection | Phase 2 | Completed | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan | 301 | 2021-06-01 | 2023-05-17 |
| Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPC Polaprezinc group, Control group - Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Completed | Jiangnan University | 12 | 2021-01-06 | 2023-07-11 |
| Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients Convalescent anti-SARS-CoV-2 MBT plasma, Control Group - SARS-CoV-2 Infection, Safety and Efficacy | Phase 2 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 384 | 2020-11-10 | 2021-09-08 |
| A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity monosialic gangliosides, Placebo - Early Breast Cancer | Phase 2 | Completed | Henan Cancer Hospital | 159 | 2020-08-28 | 2023-12-04 |
| Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients Carvacrol, Control group - COVID-19, COVID-19 Pneumonia | Phase 2 / Phase 3 | Completed | Instituto Venezolano de Investigaciones Cientificas | 600 | 2020-08-01 | 2022-07-08 |
| The Safety and Efficacy Evaluation of Hair Products Containing Probiotics Test group Probiotic Shampoo, Placebo group - Skin Problems | Phase 2 | Completed | GenMont Biotech Incorporation | 21 | 2020-07-06 | 2021-08-18 |
| Iron Supplements Effect on b-Phe Levels in PKU Patients During 3 Years Study iron supplementation, control group - Phenylketonuria (PKU) | Phase 2 | Completed | ASST Santi Paolo e Carlo | 84 | 2020-01-07 | 2025-01-24 |
| Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Carotenoid Group, Control Group - Nutrient Deficiency, Pregnancy Related | Phase 2 | Completed | Paul S. Bernstein | 47 | 2019-09-26 | 2023-07-11 |
| Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears Experimental Group, Control Group - Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Rupture | Phase 2 | Completed | Andrews Research & Education Foundation | 24 | 2019-09-12 | 2025-02-17 |
| The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis Control group, Montelukast group - Steatohepatitis, Nonalcoholic | Phase 1 / Phase 2 | Completed | Sadat City University | 56 | 2019-08-01 | 2022-03-16 |
| the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma Dexmedetomidine, General anesthetic - Pheochromocytoma | Phase 2 | Completed | National Cancer Institute, Egypt | 30 | 2019-06-30 | 2021-09-01 |
| Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection Study Group, Control Group - Renal Transplant Infection | Phase 2 | Completed | University of Alabama at Birmingham | 89 | 2019-05-09 | 2023-07-27 |
Showing 20 of 47. Sign in to see all of them.
COVID-19 (3) · Pain, Postoperative (3) · Breast Neoplasms (2) · Stroke (2) · Abdominal Pain (1) · Acquired Immunodeficiency Syndrome (1) · Acute Kidney Injury (1) · Agnosia (1) · Alcoholism (1) · Amaurosis Fugax (1) · Amyotrophic Lateral Sclerosis (1) · Anterior Cruciate Ligament Injuries (1) · Atherosclerosis (1) · Bronchopulmonary Dysplasia (1) · Carotid Stenosis (1)
National Cancer Institute, Egypt (3) · Assiut University (2) · ASST Santi Paolo e Carlo (1) · Abdelrady S Ibrahim, MD (1) · AdvanceCor GmbH (1) · Alhasan Mujtaba Abdul-Wahid (1) · Andrews Research & Education Foundation (1) · Beijing Tiantan Hospital (1) · Corestemchemon, Inc. (1) · French Cardiology Society (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1) · GenMont Biotech Incorporation (1) · Henan Cancer Hospital (1) · Hubert Ballard (1) · Instituto Nacional de Salud Publica, Mexico (1)
Egypt (9) · United States (8) · China (3) · Brazil (2) · Canada (2) · France (2) · India (2) · Iran (2) · South Korea (2) · Turkey (Türkiye) (2) · Australia (1) · Germany (1) · Indonesia (1) · Iraq (1) · Italy (1)
Ehab H Shaker, MD (3) · Adam W Anz, MD (1) · Ahmed Mohamed El Rawdy, Professor (1) · Alhasan Mujtaba, BCPS (1) · Amir Moeintaghavi, DDS.,Ms. (1) · Assad H Kata, Ph.D (1) · Carlos CP Oliveira (1) · Carlos Tene, DS (1) · Ching-Gong Lin, PhD (1) · Claudia RF Andrade, Professor (1) · David Fleischer, MD (1) · Dilek MD Metin Yamac (1)
PMID 10459293, PMID 11530753, PMID 12141594, PMID 14640675, PMID 15026283, PMID 15110326, PMID 17450108, PMID 18566668, PMID 20963840, PMID 21813309, PMID 21873560, PMID 22369555, PMID 22808958, PMID 24431901, PMID 25934946, PMID 26797689, PMID 26924470, PMID 29785539, PMID 30048006, PMID 30525951, PMID 30864096, PMID 31980156, PMID 32461102, PMID 33888136, PMID 34214585, PMID 35150610, PMID 35291004, PMID 35546145, PMID 35695006, PMID 37247819, PMID 37753336, PMID 38093975, PMID 38584600, PMID 39179054, PMID 39563399, PMID 40052182, PMID 41080591, PMID 41276263, PMID 42431386, PMID 503651, PMID 5447890, PMID 8444222
R01AA014270 (1), R01HD074944 (1), U19AI066738 (1)